40
Hepion Pharmaceuticals, Inc. raises $700K under Reg D
Company raise · Closed · Offering $700K · Sold $700K · RED BANK, NJ · filed 2026-04-22
45
Hepion Pharmaceuticals, Inc. raises $3.1M under Reg D
Company raise · Closed · RED BANK, NJ · Form D filed 2026-08-05
Placement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Gary S. Stetz, II | Director |
| Gary Stetz | Interim Chief Executive Officer |
| Sireesh Appajosyula | Director |
| Dania Fisher | Director |
| Vincent LoPriore | Executive Chairman |
| Chase LoPriore | Director |
| Michael Purcell | Director |
Signed by Gary Stetz, Interim Chief Executive Officer.
Placement agents / sales compensation: Not applicable.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.